2cureX advances towards IVD-R compliance by securing a contract with a Notified Body

2cureX advances towards IVD-R compliance by securing a contract with a Notified Body2cureX, a company pioneering the use of 3D tumoroids for drug sensitivity prediction in patients with cancer, announced today the signature of a contract with a Notified Body under Regulation (EU) 2017/746 on in vitro diagnostic medi...

Related Keywords

Stockholm ,Sweden ,Emanuel Martin ,Fernando Andreu ,Regulatory Affairs ,Medtech Europe The European Medical Technology ,Notified Body ,Conformity Assessment ,Notified Bodies ,Medical Devices ,European Directives ,Technical Files ,Quality Management Systems ,European Medical Technology ,Quality Assurance ,Person Responsible ,Regulatory Compliance ,Quality Management System ,Chief Executive ,Individual Treatment ,Vitro Diagnostic ,Precision Oncology ,Nasdaq First North Growth Market ,